Promptly
A global provider of end-to-end Real-World Evidence solutions, generating new knowledge from harmonized datasets to improve healthcare outcomes at lower costs.
- B2B
- saas
- commission
- subscription
- health
- enterprise software
- pharmaceutical
- health platform
- medical devices
- artificial intelligence
- big data
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | - | |
| Total Funding | 000k | ||
| EUR | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 16 % | 135 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | (80 %) | (89 %) | (28 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Promptly is an emerging global provider of end-to-end Real-World Evidence solutions, connecting healthcare organizations with life sciences companies.
The company is building a patient-centered global evidence network, offering real-world data sharing and monetization capabilities. It generates new knowledge from harmonized high-quality clinical, socio-economic, and claims data, augmented with the collection of longitudinal patient-reported data. This allows for the tracking of treatment over time and understanding of condition progression.
Promptly also offers patient engagement software that supercharges Patient Management Systems (PMS), making repetitive tasks and touchpoints quicker and easier. The company empowers patients to actively participate in their care and engage in their health journey.
In a strategic move to address the fragmented health data landscape in Europe, Promptly has partnered with Datavant. This collaboration aims to advance European health data and obtain multi-source Real World Evidence from both sponsored collection and existing data.
Keywords: Real-World Evidence, RWE, patient-reported data, data harmonization, patient engagement, healthcare data, life sciences, clinical data, data monetization, health outcomes